Abstract

Background: Saturated fat (SFA) has consistently been shown to increase liver fat, but the response appears variable at the individual level. Phenotypic and genotypic characteristics have been demonstrated to modify the hypercholesterolemic effect of SFA but it is unclear which characteristics that predict liver fat accumulation in response to a hypercaloric diet high in SFA.Objective: To identify predictors of liver fat accumulation in response to an increased intake of SFA.Design: We pooled our two previously conducted double-blind randomized trials (LIPOGAIN and LIPOGAIN-2, clinicaltrials.gov NCT01427140 and NCT02211612) and used data from the n = 49 metabolically healthy men (n = 32) and women (n = 17) randomized to a hypercaloric diet through addition of SFA-rich muffins for 7–8 weeks. Associations between clinical and metabolic variables at baseline and changes in liver fat during the intervention were analyzed using Spearman rank correlation. Linear regression was used to generate a prediction model.Results: Liver fat increased by 33% (IQR 5.4–82.7%; P < 0.0001) in response to excess energy intake and this was not associated (r = 0.17, P = 0.23) with the increase in body weight (1.9 kg; IQR 1.1–2.9 kg). Liver fat accumulation was similar (P = 0.28) in carriers (33%, IQR 14–79%) and non-carriers (33%, IQR −11 to +87%) of the PNPLA3-I148M variant. Baseline visceral and liver fat content, as well as levels of the liver enzyme γ-glutamyl transferase (GT), were the strongest positive predictors of liver fat accumulation—in contrast, adiponectin and the fatty acid 17:0 in adipose tissue were the only negative predictors in univariate analyses. A regression model based on eight clinical and metabolic variables could explain 81% of the variation in liver fat accumulation.Conclusion: Our results suggest there exists a highly inter-individual variation in the accumulation of liver fat in metabolically healthy men and women, in response to an increased energy intake from SFA and carbohydrates that occurs over circa 2 months. This marked variability in liver fat accumulation could largely be predicted by a set of clinical (e.g., GT and BMI) and metabolic (e.g., fatty acids, HOMA-IR, and adiponectin) variables assessed at baseline.

Highlights

  • The etiology behind excessive accumulation of fat in the liver is multifactorial and can have metabolic and/or genetic origin

  • Intake of total fat increased by a median of 3%E (IQR 1.2–7.7%E, P < 0.0001), from 37.1%E (IQR 31.7–41.1%E) at baseline to 40.0%E (IQR 37.1–44.1%E) at the end of the intervention whereas intake of protein decreased by a median of 3.0%E (IQR 4.8–0.7%E, P < 0.0001), from 15.9%E (IQR 14.0–17.2%E) at baseline to 13.0%E (IQR 11.2–15.1%E) at the end of the intervention

  • It has previously been reported that the effect of dietary saturated fat (SFA) on atherogenic lipids in subjects with obesity was only about ∼50% of the effect observed in subjects with normal body weight [16, 17], but no data on liver fat content per se has been reported

Read more

Summary

Introduction

The etiology behind excessive accumulation of fat in the liver (non-alcoholic fatty liver disease, NAFLD) is multifactorial and can have metabolic and/or genetic origin. Results from intervention trials demonstrate that the inter-individual change in liver fat accumulation in response to dietary SFA is quite considerable [6,7,8, 10], implying that phenotypic and/or genotypic characteristics exert strong modulatory effects. Such individual responses to SFA have previously been demonstrated for blood lipids, where the effect of dietary SFA on LDL cholesterol and apolipoprotein B levels are about half the magnitude in subjects with obesity compared with normal-weight subjects [16, 17].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call